Physician Wealth Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65K Buy
67
+39
+139% +$1.9K ﹤0.01% 1240
2026
Q1
$1.2K Hold
28
﹤0.01% 1574
2025
Q4
$1.23K Sell
28
-12
-30% -$496 ﹤0.01% 1511
2025
Q3
$1.65K Sell
40
-6
-13% -$241 ﹤0.01% 1313
2025
Q2
$2.03K Buy
46
+28
+156% +$1.12K ﹤0.01% 1040
2025
Q1
$665 Buy
+18
New +$641 ﹤0.01% 1298

Other funds holding EXEL

Physician Wealth Advisors's EXEL Position: Q2 2026 in Review

Physician Wealth Advisors increased its Exelixis (EXEL) stake by 139% in Q2 2026, buying an estimated $1.9K and bringing the position to 67 shares worth $3.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Physician Wealth Advisors first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Physician Wealth Advisors held 67 shares of Exelixis worth $3.65K as of Q2 2026.
  • Physician Wealth Advisors bought 39 Exelixis shares in Q2 2026, an estimated $1.9K.
  • Exelixis made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1240 holding.
  • Physician Wealth Advisors first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.